🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
The aim of this research is to evaluate the potential interest of an associ...
Status
Completed
Location
Centre François BACLESSE
Start Date
2010-06
Trial ID
NCT01165385
Chemotherapy treatment with docetaxel and gemcitabine is a standard treatme...
Status
Completed
Location
Fletcher Allen Health Care
Start Date
2012-10
Trial ID
NCT01719302
Treatments Being Tested
This phase I trial studies the side effects and best dose of pazopanib hydr...
Status
Completed
Location
Washington University School of Medicine
Start Date
2013-05-31
Trial ID
NCT01716416
This is an open-label, multicenter dose-escalation phase I study using a 3+...
Status
Completed
Location
Centre Léon BERARD
Start Date
2010-07
Trial ID
NCT01202032
Treatments Being Tested
This study is being conducted to compare the efficacy and safety of pazopan...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07
Trial ID
NCT00347919
This clinical trial shall clarify the efficacy and safety of pazopanib in c...
Status
Unknown
Location
Charité Campus Virchow-Klinikum
Start Date
2012-05
Trial ID
NCT01600573
Treatments Being Tested
Pazopanib monotherapy is approved by the Food and Drug Administration (FDA)...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02367651
Treatments Being Tested
This is an open-label, multicenter, non-randomized, phase 1 dose escalation...
Status
Terminated
Location
Hôpital Saint André
Start Date
2012-11-22
Trial ID
NCT01642017
Treatments Being Tested
The current trial shall clarify the potential of the multitarget antiangiog...
Status
Completed
Location
Marienkrankenhaus Hamburg
Start Date
2010-11
Trial ID
NCT01238770
Treatments Being Tested